All you need to know about ESMO discussions on Twitter.
November 11, 2022Our Insights,big datasocial media intelligence,healthcare consulting,social media analysis,social media analytics,ESMO 2020,ESMO 2021,ESMO 2022,Conference Social Media Reports
The European Society for Medical Oncology (ESMO) is a leading point of…
Will a Value-based Payment system improve patient care and lower healthcare costs in the US?
November 8, 2022Our Insightsvalue-based healthcare,health crisis,US health crisis,health policy
In the US, fee-for-service (FFS) is the most commonly used payment method for…
Dancing to the tunes of music therapy health interventions coming of age.
October 15, 2022Our Insightsdigital health,digital therapeutics,music therapy,neurorehabilitation,Alzheimer's Disease,MS music therapy
"Music can lift us out of depression or move us to tears - it is a remedy, a…
Watch out for your heart! Digital health apps to improve cardiovascular disease care.
October 10, 2022Our Insights,digital healthmhealth,health apps,heart apps,digital health apps,cardiovascular disease management,AI healthcare,cardiovascular,Cardiovascular News,Cardiovascular News
Cardiovascular disease is a leading cause of death worldwide; the WHO estimated…
Replication/ reproducibility crisis in preclinical studies. Is the end "in sight"?
October 5, 2022Our Insightspreclinical research,drug discovery,reproducibility crisis,replication crisis,preclinical studies,drug evaluation,drug development,safety pharmacology,advanced therapies
Scientific development relies on knowledge/research credibility and validity.…
What a Linkedin poll revealed about the Gene Therapy challenges.
October 1, 2022Our Insightsbiotech,clinical trials,drug development,Regulatory,CGT,advanced Therapy,Medicare,cell and gene therapy,gene therapy challenges,MS-DRG
With over 2 million groups where professionals from various industries network,…
How will AI transform the way we treat cancer?
September 20, 2022Our InsightsOncology,cancer treatment,AI healthcare,ESMO 2022,AI oncology,digital health innovation,cancer genetics research
Cancer is one of the top causes of death worldwide. According to the American…
Oncolytic viruses: From promise to reality
September 7, 2022Our InsightsOncology,oncolytic virotherapy,cancer treatment,cancer research,oncolytic viruses,Amgen,Rigvir,Oncorine,Delytact
The countless cytotoxic effects of traditional chemotherapy have created the…
AAV-based gene therapies: Safe or not? Challenges and considerations for the future.
September 5, 2022Our InsightsAAV,AAV-based gene therapies,AAV challenges,AAV adverse events,AAV and liver toxicity,AAV and tumorigenesis
Adeno-associated virus (AAV) is one of the most studied gene therapy vehicles.…
Launching digital health products; don’t make it a space Odyssey!
August 25, 2022Our Insightshealth apps,go to market strategy,GTM startegy,digital healthcare,health digital solutions
Digital healthcare was a rapidly evolving space even before the pandemic, while…
Hospital-Acquired Infections (HAIs) in the U.S. - The nightmare continues!
August 21, 2022Our InsightsHAIS,HOSPITAL-ACQUIRED INFECTIONS,nosocomial infections,healthcare associated infections
Hospital-acquired infections (HAIs) or nosocomial infections are diseases…
Decentralized Clinical Trials (DCTs) in Oncology – Is the Pharma Industry ready?
August 19, 2022Our InsightsOncology,clinical trials,decentralized trials,vitual trials,oncology trials,complex innovative design
The acceptance of telehealth and the incorporation of digital technologies have…











